Prevalence of serum IgG antibodies to hepatitis A virus in Cambridge haemophiliacs.
Richards
E M
EM
Wreghitt
T G
TG
Baglin
T P
TP
D015897:Comorbidity; D004739:England / Q000453:epidemiology; D005164:Factor IX / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D006467:Hemophilia A / Q000453:epidemiology* / Q000628:therapy; D006506:Hepatitis A / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D035922:Hepatitis A Antibodies; D022362:Hepatitis A Vaccines; D006508:Hepatitis Antibodies / Q000097:blood*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood* / Q000276:immunology; D015995:Prevalence; D014761:Viral Hepatitis Vaccines
D035922:Hepatitis A Antibodies; D022362:Hepatitis A Vaccines; D006508:Hepatitis Antibodies; D007074:Immunoglobulin G; D014761:Viral Hepatitis Vaccines; D005169:Factor VIII; D005164:Factor IX